XARELTO® (rivaroxaban) | Stroke Risk Reduction in NVAF, DVT and PE Risk Reduction & Prophylaxis
XARELTO® (rivaroxaban) is a Factor Xa inhibitor with six indications including reducing the risk of stroke and systemic embolism in patients with NVAF, the treatment of DVT, PE and DVT prophylaxis after knee or hip replacement surgery.
xarelto hcp, rivaroxaban, xarelto indications, atrial fibrillation treatment, blood clot prevention, deep vein thrombosis prophylaxis, deep vein thrombosis treatment, dvt treatment, pulmonary embolism treatment, xarelto reimbursement, xarelto studies
Is this your site? Certify your site and update informations
